Post

New research · Ophthalmology
Cardiovascular and interventional radiology · 1d
Cohort studyCardiovascular and interventional radiology · 2026

Intra-Arterial Chemotherapy for Advanced Intraocular Retinoblastoma….

Sena Bozer Uludağ, Emre Can Çelebioğlu, Emre Utkan Büyükceran … Sadık Bilgiç
Read paper
OphthalmologyCohort study

Vision was maintained or improved in most eyes after intra-arterial chemotherapy for retinoblastoma.

Intra-Arterial Chemotherapy for Advanced Intraocular Retinoblastoma….

Sena Bozer Uludağ … Sadık Bilgiç
Cardiovascular and interventional radiology · 2026
Purpose

To evaluate the safety and efficacy of intra-arterial chemotherapy as a treatment for advanced intraocular retinoblastoma and to present our single-center experience.

Methods

This single-center retrospective cohort study included 13 pediatric patients (15 eyes) who underwent intra-arterial chemotherapy between January 2020 and December 2024.

n = 15 eyes
93.3%
Results
93.3%
vision stayed the same or got better in almost all eyes treated
n = 15 eyes
More results

According to the ICRB classification, most eyes (66.7%) were Groups D, followed by groups C and E.

The mean age at presentation was 22.5 months.

Minor procedural complications were observed in 8.8% of sessions, with no serious systemic adverse events.

More results

No patients required enucleation, and no cases of metastasis or death occurred during follow-up.

“
Conclusion · 1 of 2

Intra-arterial chemotherapy is a technically feasible and promising globe-sparing treatment for intraocular retinoblastoma, demonstrating high technical success and a favorable safety profile in our cohort.

Conclusion · 2 of 2

While preliminary outcomes show preserved visual function and high ocular survival, larger studies with longer follow-up are necessary to confirm long-term efficacy and safety within a multidisciplinary framework.

Read paper
0 comments

No comments yet. Be the first.

Related papers

LatestFoundational
Cross-sectional
44.1%
had too much homocysteine in the blood, a far larger share than in dry AMD or healthy eyes
Cohort Study
92.3%
most laser-treated eyes had a favorable eye-structure outcome
Cohort Study
56%
lost three or more lines on the eye-chart vision test
Cohort Study
50%
older patients were more likely to lose three or more lines of vision
Study
81%
trials where mask air leaks were detected blowing toward the eyes
Cohort Study
13.5%
Central retinal artery peak blood-flow speed was 13.5% lower in diabetic patients.
Study
379 +/- 156 microm
lower thickness in the central retina, checked with an eye scan
Case Report
9 of 10 eyes
eyes had better measured vision after treatment